Fundraising Fox

VeriSIM Life

9 known investors

verisimlife.com β†—

VeriSIM uses machine learning and computational simulation to accelerate drug development, replacing traditional trial-and-error experimentation with computational prediction to improve success rates and reduce animal testing. The company serves pharmaceutical partners and research institutions developing new medicines.

AI & Machine LearningBiotechDigital HealthMedical Devices

Founders & leadership

DJ
Dr. Jo Varshney
JV
Jo VarshneyinFounder

Investors Β· 9

Competitors Β· 2

by search overlap

Companies competing with VeriSIM Life for the same Google search keywords, organic and paid, via search-intersection analysis.

Non-dilutive funding Β· 2 SBIR/STTR awards

Federal grants β€” no equity taken
AgencyPhaseYearAmount
National Institutes of Health (NIH)National Institutes of HealthPhase I2022$312.3K
National Science FoundationPhase I2021$255.9K

Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts β€” non-dilutive capital alongside any venture rounds above.

Frequently asked questions

What does VeriSIM Life do?
VeriSIM uses machine learning and computational simulation to accelerate drug development, replacing traditional trial-and-error experimentation with computational prediction to improve success rates and reduce animal testing. The company serves pharmaceutical partners and research institutions developing new medicines.
Who founded VeriSIM Life?
VeriSIM Life was founded by Dr. Jo Varshney, Jo Varshney.
Who are VeriSIM Life's investors?
VeriSIM Life's investors include Amplify Partners, Cerity Partners Ventures, Intel Capital, Loup Ventures, OCA Ventures, Twin Ventures, Village Global, Serra Ventures and 1 more.